Benign prostatic hyperplasia: diagnosis and treatment. Benign Prostatic Hyperplasia Guideline Panel. Agency for Health Care Policy and Research.
D000317:Adrenergic alpha-Antagonists / Q000627:therapeutic use; D000368:Aged; D000369:Aged, 80 and over; D002404:Catheterization; D002985:Clinical Protocols; D003663:Decision Trees; D003937:Diagnosis, Differential; D018120:Finasteride / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008875:Middle Aged; D010353:Patient Education as Topic; D015995:Prevalence; D011468:Prostatectomy; D011470:Prostatic Hyperplasia / Q000145:classification / Q000150:complications / Q000175:diagnosis* / Q000453:epidemiology / Q000628:therapy*; D012307:Risk Factors; D012720:Severity of Illness Index; D016896:Treatment Outcome
D000317:Adrenergic alpha-Antagonists; D018120:Finasteride